IL1B and colonic neoplasm: We subsequently tested if the altered expression in IL-6 and IL-1β would affect the tumor microenvironment and modify signaling in colon cancer cells by treating COLO205 cells with the supernatant from THP1 transfected cells combined with regular growth media (1:1) followed by cell growth for 72 h.